Published in Int J Stem Cells on May 30, 2016
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis. Int J Stem Cells (2016) 0.75
Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol (1997) 15.19
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 11.77
Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol (2005) 9.19
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 3.02
A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum (2005) 2.65
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci (2011) 2.61
The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev (2009) 2.55
Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A (2003) 2.20
Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol (2013) 2.04
Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells. Nat Methods (2011) 1.85
Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ (2006) 1.79
Stability of the gross motor function classification system. Dev Med Child Neurol (2006) 1.76
Cerebral palsy in Norway: prevalence, subtypes and severity. Eur J Paediatr Neurol (2007) 1.63
The relationship of cerebral palsy subtype and functional motor impairment: a population-based study. Dev Med Child Neurol (2009) 1.47
The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology (2008) 1.46
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant (2007) 1.43
Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res (2006) 1.41
A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab (2007) 1.39
The past, present and future of stem cell clinical trials for ALS. Exp Neurol (2014) 1.27
Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplant (2012) 1.17
Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy. J Transl Med (2012) 1.16
Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol (2007) 1.07
Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections. Restor Neurol Neurosci (2011) 1.05
Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol (2008) 1.03
Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol (2009) 1.01
Therapeutic potential of autologous stem cell transplantation for cerebral palsy. Case Rep Transplant (2012) 0.96
Musculoskeletal complications of neuromuscular disease in children. Phys Med Rehabil Clin N Am (2008) 0.91
Potential neuronal repair in cerebral white matter injury in the human neonate. Pediatr Res (2011) 0.90
Neural stem cells: from neurobiology to clinical applications. Curr Pharm Biotechnol (2013) 0.86
Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors. Ann Hematol (2008) 0.82
Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case Rep Transplant (2013) 0.81
Children with cerebral palsy: a systematic review and meta-analysis on gait and electrical stimulation. Clin Rehabil (2010) 0.79
Disabling chronic conditions in childhood and socioeconomic disadvantage: a systematic review and meta-analyses of observational studies. BMJ Open (2015) 0.79